Anika Therapeutics | ANIK

Anika Therapeutics traded at $22.51 this Friday July 1st, increasing $0.19 or 0.85 percent since the previous trading session. Looking back, over the last four weeks, Anika Therapeutics gained 2.23 percent. Over the last 12 months, its price fell by 49.04 percent. Looking ahead, we forecast Anika Therapeutics to be priced at 21.90 by the end of this quarter and at 20.17 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Abbott 110.22 1.57 1.45% -6.62%
Acorda Therapeutics 0.48 0.01 3.20% -89.34%
Agenus 1.96 0.02 1.03% -64.49%
Agios Pharmaceuticals 23.36 1.19 5.37% -58.08%
Anika Therapeutics 22.51 0.19 0.85% -49.04%
Arrowhead Research 35.96 0.75 2.13% -43.04%
ChemoCentryx 26.76 1.98 7.99% 103.03%
Clovis Oncology 2.85 1.05 58.33% -49.91%
Enanta Pharmaceuticals 49.63 2.36 4.99% 12.29%
Halozyme Therapeutics 44.48 0.48 1.09% -4.18%
Heron Therapeutics 2.72 -0.07 -2.51% -81.71%
Integra LifeSciences 55.00 0.97 1.80% -21.32%
Immunogen 4.61 0.11 2.44% -28.30%
Insmed 20.89 1.17 5.93% -26.70%
J&J 179.52 2.01 1.13% 6.24%
Karyopharm Therapeutics 4.73 0.22 4.88% -55.00%
Ligand Pharmaceuticals 90.58 1.36 1.52% -32.02%
MacroGenics 3.05 0.10 3.39% -89.37%
Merit Medical Systems 54.96 0.69 1.27% -14.15%
Peregrine Pharmaceuticals 15.33 0.07 0.46% -41.38%
Rigel Pharmaceuticals 1.25 0.12 10.62% -71.66%
Sanofi 97.53 -0.81 -0.82% 12.40%
Sangamo BioSciences 4.28 0.14 3.38% -63.45%
Smith & Nephew PLC 1,126.50 -13.50 -1.18% -29.13%
Surmodics 37.82 0.59 1.58% -30.38%
Stryker 203.86 4.93 2.48% -23.19%
Veracyte 21.10 1.20 6.03% -46.58%
Xencor 28.86 1.49 5.44% -18.43%
Intrexon 1.41 0.07 5.22% -78.04%
Zimmer Biomet Holdings Inc 107.27 2.21 2.10% -34.40%

Indexes Price Day Year
USND 11128 99.11 0.90% -23.99%
US2000 1728 19.77 1.16% -25.07%

Anika Therapeutics
Anika Therapeutics, Inc. is a joint preservation company. The Company creates and delivers advancements in early intervention orthopedic care, including in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. It is focused on developing, manufacturing, and commercializing products based on its hyaluronic acid (HA) technology platform. Its product categories include joint pain management therapies, joint preservation and restoration care, and Other. The joint pain management therapies offer injectable viscosupplement products that provide pain relief from osteoarthritis conditions and its products include MONOVISC, ORTHOVISC, CINGAL and HYVISC. Its joint preservation and restoration care products include HYALOFAST and TACTOSET. Its Other product family consists of Hyalobarrier and Hyaloglide.